TABLE 4.
Demographic, clinical, and pathologic characteristics of the patient with breast cancer.
Variable | All dataset |
Validation dataset |
||||||||
Total | Risk group |
χ2 | P-value | Total | Risk group |
χ2 | P-value | |||
Lower | Higher | Lower | Higher | |||||||
|
|
|
|
|
|
|||||
n = 962 | n = 624 | n = 338 | n = 481 | 321 | 160 | |||||
Age (years) | ||||||||||
≤40 | 87 | 59 | 28 | 0.545 | 0.762 | 44 | 31 | 13 | 0.322 | 0.851 |
41–60 | 446 | 285 | 161 | 228 | 152 | 76 | ||||
≥61 | 429 | 280 | 149 | 209 | 138 | 71 | ||||
Subtype (PAM50) | ||||||||||
LumA | 456 | 353 | 103 | 92.295 | 0.000 | 240 | 186 | 54 | 45.400 | 0.000 |
LumB | 164 | 90 | 74 | 70 | 41 | 29 | ||||
HER2 | 67 | 19 | 48 | 33 | 11 | 22 | ||||
Basal | 157 | 80 | 77 | 85 | 42 | 43 | ||||
Normal | 118 | 82 | 36 | 53 | 41 | 12 | ||||
Tumor size | ||||||||||
T1 | 248 | 183 | 65 | 18.447 | 0.000 | 136 | 98 | 38 | 2.484 | 0.478 |
T2 | 560 | 340 | 220 | 274 | 178 | 96 | ||||
T3 | 126 | 88 | 38 | 60 | 38 | 22 | ||||
T4 | 28 | 13 | 15 | 11 | 7 | 4 | ||||
Lymph node status | ||||||||||
N0 | 466 | 299 | 167 | 2.551 | 0.466 | 253 | 165 | 88 | 1.756 | 0.624 |
N1 | 324 | 207 | 117 | 154 | 102 | 52 | ||||
N2 | 107 | 70 | 37 | 45 | 32 | 13 | ||||
N3 | 65 | 48 | 17 | 29 | 22 | 7 | ||||
Metastasis status | ||||||||||
M0 | 948 | 616 | 332 | 0.372 | 0.542 | 472 | 315 | 157 | 0.000 | 0.996 |
M1 | 14 | 8 | 6 | 9 | 6 | 3 |